tm logo

Monitor this mark

View On USPTO

PRADAXA
Live/Registered
REGISTERED AND RENEWED

on 27 Oct 2021

Last Applicant/ Owned by

Boehringer Ingelheim Pharma GmbH & Co.,KG

Binger Strasse 173

Ingelheim

DE

55218

Serial Number

85133694 filed on 20th Sep 2010

Registration Number

3977066 registered on 14th Jun 2011

in the Principal Register

Correspondent Address

Sean P. McMahon

Sean P. McMahon

845 Third Avenue, 8th Floor

NEW YORK NY 10022

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

PRADAXA

Pharmaceutical preparations and substances for the treatment of blood and blood forming organs as well as for the treatment of the cardiovascular system

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations and substances for the treatment of blood and blood forming organs as well as for the treatment of the cardiovascular system

First Use Date in General

26th Oct 2010

First Use Date in Commerce

26th Oct 2010

Mark Details

Serial Number

No 85133694

Mark Type

No Service/Collective Mark

Attorney Docket Number

No TE/3975-178

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
27th Oct 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
27th Oct 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
27th Oct 2021REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
27th Oct 2021REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
14th Jun 2021TEAS SECTION 8 & 9 RECEIVED
14th Jun 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
21st Jul 2017REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
21st Jul 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
21st Jul 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
31st May 2017TEAS SECTION 8 & 15 RECEIVED